Sort
48,018 grants matching “immunotherapy”
Mechanisms Underlying Clearance of Persistent Infections
$1,513,172Dorian McGavern · National Institute Of Neurological Disorders And Stroke · ZIA · FY2013 · NS
Building a Systems Immunopeptidomics Framework to Challenge the Current T Cell Activation Paradigm
$1,512,500Etienne Caron · Yale University · DP2 · FY2025 · CA
Clinical and Mechanistic Investigations of Salivary Gland Dysfunction
$1,512,283Blake Warner · National Institute Of Dental & Craniofacial Research · ZIA · FY2023 · DE
Dissecting the enhancer logic governing immune cell fate decisions
$1,512,000Debattama Rai Sen · Massachusetts General Hospital · DP2 · FY2022 · AI
Development of Innovative Resources to Advance MDS Research
$1,511,993Marie Bleakley · Fred Hutchinson Cancer Center · RC2 · FY2024 · DK
Neuro-oncology
$1,511,881Edward H Oldfield · Neurological Disorders And Stroke · Z01 · FY2007 · NS
HAWAII ACTU - ADULT THERAPEUTIC CLINICAL TRIALS PROGRAM
$1,511,671University Of Hawaii At Manoa · U01 · FY2003 · AI
Immunotherapeutic Approaches for AIDS
$1,511,661George N. Pavlakis · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
GENERAL CLINICAL RESEARCH CENTER
$1,511,495University Of Connecticut Sch Of Med/Dnt · M01 · FY2000 · RR
ADULT AIDS CLINICAL TRIALS UNIT
$1,511,271University Of California San Francisco · U01 · FY2004 · AI
Adoptive T cell Therapy for Pediatric Leukemia
$1,511,241Terry Fry · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
Immunological Strategies to Modulate SIV Rebound Following ART Interruption
$1,510,883Michael R Betts · University Of Pennsylvania · P01 · FY2020 · AI
ADULTS AIDS CLINICAL TRIALS UNIT UPR ADULT ACTU
$1,510,774University Of Puerto Rico Med Sciences · U01 · FY2001 · AI
The connection of innate and adaptive anti-cancer immunity
$1,510,560John Greiner · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
Characterization and Enhancement of Anti-Tumor Immune Responses in Head and Neck Cancer
$1,510,517Clint Allen · National Institute On Deafness And Other Communication Disorders · ZIA · FY2017 · DC
BIOLOGY AND TRANSPLANTATION OF THE HUMAN STEM CELL
$1,509,110University Of Minnesota Twin Cities · P01 · FY2003 · CA
RNA TRASFECTED DENDRITIC CELLS FOR CANCER IMMUNOTHERAPY
$1,508,679Duke University · P01 · FY2001 · CA
Programming cellular behavior by mechanical forces
$1,508,357Julien Berro · Yale University · R01 · FY2024 · EB
Therapy for NF1-Related Tumors and other Genetic Tumor Predisposition Syndromes
$1,507,659Brigitte Widemann · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Unleashing T-cell anti-tumor response through repair of altered RNA splicing and antigen mimicry recognition
$1,507,500Luisa Escobar Hoyos · Yale University · DP2 · FY2022 · CA
Deconvolution and interruption of the cancer-neuro-immune axis facilitating brain metastases
$1,506,650Melanie Hayden Gephart · Stanford University · U54 · FY2021 · CA
Immunotherapy for Malignant Mesothelioma, Lung Cancer and Thymic Malignancies
$1,506,569Raffit Hassan · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Innate Immune Antivirals for Biodefense
$1,506,330Michael J Gale · University Of Washington · R01 · FY2012 · AI
Multidisciplinary Collaborative Research in NIDDK Program Area Diseases
$1,506,257James Balow · National Institute Of Diabetes And Digestive And Kidney Diseases · ZID · FY2009 · DK
Dissecting the mechanisms of HIV resistance in vivo to broadly neutralizing antibodies
$1,504,603Alon Herschhorn · University Of Minnesota · U01 · FY2022 · AI